HopeStage
Back to all studies
CompletedNCT04827901

Studying XEN1101 as a treatment for major depression

About this titleRead the official source — NCT04827901
Medication studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
New York and 1 more locationSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 19, 2021
Recruitment status
Completed
Enrollment listed in the registry
44
Sponsor
James Murrough
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT04827901
Official title
Show the full official title

A Proof of Concept Randomized Controlled Trial of XEN1101 for the Treatment of Major Depressive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New York · Houston

Study drug

About the molecule

When a study medicine is clearly identified, HopeStage adds a short explanation of what that molecule is and links back to reliable public sources.

Azetukalner

an experimental Kv7 potassium-channel opener

targets Kv7 potassium channels

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is James Murrough.

Did this study involve medication?

Yes. The study involved medication, including XEN1101 and Placebo.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies